$176 Million is the total value of First Light Asset Management, LLC's 66 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENDP | ENDO INTL PLCcs | $589,000 | +5.6% | 8,161 | 0.0% | 0.33% | -12.6% | |
| NVS | NOVARTIS A Gadr | $562,000 | -1.6% | 6,070 | 0.0% | 0.32% | -18.7% | |
| MYL | MYLAN LABS INCcs | $551,000 | +23.8% | 9,775 | 0.0% | 0.31% | +2.6% | |
| B108PS | ACTAVIS PLCcs | $524,000 | +6.7% | 2,035 | 0.0% | 0.30% | -11.6% | |
| HUM | HUMANA INCcs | $508,000 | +10.2% | 3,540 | 0.0% | 0.29% | -8.6% | |
| UTHR | UNITED THERAPEUTICS CORP DELcs | $495,000 | +0.8% | 3,820 | 0.0% | 0.28% | -16.4% | |
| BMY | BRISTOL MYERS SQUIBB COcs | $489,000 | +15.3% | 8,290 | 0.0% | 0.28% | -4.5% | |
| CELG | CELGENE CORPcs | $479,000 | +18.0% | 4,280 | 0.0% | 0.27% | -2.5% | |
| AET | AETNA INC NEWcs | $463,000 | +9.7% | 5,215 | 0.0% | 0.26% | -9.3% | |
| CFN | CAREFUSION CORPcs | $459,000 | +31.1% | 7,730 | 0.0% | 0.26% | +8.8% | |
| STE | STERIS CORPcs | $411,000 | +20.2% | 6,330 | 0.0% | 0.23% | -0.4% | |
| AZN | ASTRAZENECA PLCadr | $400,000 | -1.5% | 5,680 | 0.0% | 0.23% | -18.3% | |
| JNJ | JOHNSON AND JOHNSONcs | $399,000 | -2.0% | 3,820 | 0.0% | 0.23% | -18.7% | |
| STJ | ST JUDE MED INCcs | $394,000 | +8.2% | 6,055 | 0.0% | 0.22% | -10.4% | |
| BDX | BECTON DICKINSON AND COcs | $389,000 | +22.3% | 2,795 | 0.0% | 0.22% | +0.9% | |
| LLY | LILLY ELI AND COcs | $379,000 | +6.5% | 5,495 | 0.0% | 0.22% | -11.9% | |
| MRK | MERCK N CO INC NEWcs | $375,000 | -4.3% | 6,610 | 0.0% | 0.21% | -20.5% | |
| AMGN | AMGEN INCcs | $371,000 | +13.5% | 2,330 | 0.0% | 0.21% | -6.2% | |
| CYH | COMMUNITY HEALTH SYS INC NEWcs | $331,000 | -1.8% | 6,145 | 0.0% | 0.19% | -18.6% | |
| PFE | PFIZER INCcs | $328,000 | +5.5% | 10,520 | 0.0% | 0.19% | -12.7% | |
| MYGN | MYRIAD GENETICS INCcs | $266,000 | -11.9% | 7,820 | 0.0% | 0.15% | -27.1% | |
| A | AGILENT TECHNOLOGIES INCcs | $210,000 | -28.1% | 5,120 | 0.0% | 0.12% | -40.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.